Breaking News

ExoXpert, Neucore Bio to Evaluate Advanced Exosome Loading

Aims to enable greater clarity on maximizing the therapeutic effect of Neucore’s FiXE platform as it advances clinical development.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ExoXpert, a CDMO specializing in exosome production and a subsidiary of Exo Biologics, entered a strategic partnership with Neucore Bio, a next-generation, non-viral engineered delivery technology company to leverage ExoXpert’s platform for evaluation of advanced exosome loading.   Under the agreement, ExoXpert will leverage its ExoPulse platform to test and optimize efficient loading of proprietary payloads into exosomes as part of Neucore’s Fibroblast EV Engineering (FiXE) discovery platform...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters